-
Margaret Malone
Healthtech InvestorFlare Capital -
Vrunda Desai
MD, FACOG, Vice President of Medical Affairs,CooperSurgical -
Bethany Corbin
Founder & CEOFemInnovation -
Fahimeh Sasan
Chief Innovation OfficerKindbody -
Liza Kunz
Systems Director, Endocrinology & Reproductive HealthAbbott -
Ru-fong Joanne Cheng
Director, Women’s Health InnovationsBill & Melinda Gates Foundation -
Sasha Ottey, MHA, MT, (ASCP)
Executive DirectorPCOS Challenge: The National Polycystic Ovary Syndrome Association -
Leigh Allen
Program OfficerEunice Kennedy Shriver National Institute of Child Health and Human Development -
Everett Hanford
Region 1 Director of New EnglandU.S. Department of Health and Human Services -
Daniel Johnston
Chief, Contraception Research BranchEunice Kennedy Shriver National Institute of Child Health and Human Development -
David Sable
Life Sciences Portfolio ManagerSpecial Situations Funds -
Carmen Messerlian
Founder & PresidentVie Science, Inc. -
Diana Contreras
Chief Health Strategy OfficerPlanned Parenthood Federation of America -
Jessica Bell van der Wal
Co-Founder and CEOFrame Fertility -
Nada Hanafi MSc, MPH
Founder & Manager, MedTech Strategy Advisors LLC; Co-FounderMedTech Color -
Kevin Eisenfrats
Co-Founder & CEOContraline -
Anne Morrisey
CEO and FounderMay Health -
Yaron Silberman
CEOBAIBYS™ Fertility -
Mary Frank
Director of Strategic InitiativesNational Abortion Federation -
Michelle Perugini
CEO & Co-FounderPresagen -
Anita Garg
Senior Director StrategyPopulation Council -
Christy Prada
CEOFuture Fertility -
Heather Bowerman
CEO and FounderDotLab -
Naseem Sayani
Co-Founder & Managing DirectorEmmeline Ventures -
Donna Russell
CEOPrecia Group -
Stasia Obremskey
Managing DirectorRH CapitalBefore joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar. She has lived for over 8 years in Bangkok, Thailand and Hong Kong, China. She began her consulting career as a management consultant with Bain & Company. Previously, she worked in investment banking for Morgan Stanley & Co. She holds a bachelor’s degree in Business Administration with a concentration in finance from the University of Notre Dame and an MBA from the Harvard Graduate School of Business. In addition to her consulting work, she has extensive experience as a member of several nonprofit boards where she has held a number of leadership positions.
-
Natalie Birnbaum
Principal Owner, AttorneyRepro Solutions -
Kristin Brogaard
CSO & Co-FounderInherent Biosciences Inc. -
Ashley Crafton
CEOGalena Innovations -
Valerie Palmieri
CEOMOMENTUM Consulting -
Nader AlSalim
Founder & CEOGaia -
Samantha Miller
Co-Founder & Co-CEOCadence Health -
Nigina Nuntean
Head of Innovation UnitUnited Nations Population Fund -
Monica Cepak
CEOWisp -
Mark Connell
PresidentSLBST Pharma -
Asima Ahmad
Co-Founder & Chief Medical OfficerCarrot Fertility -
Andrea Olariu
CEOMedicines360 -
David Stern
CEOBoston IVFDavid Stern has over 28 years of women’s health experience and has devoted the majority of his career to the fertility industry. He has held executive leadership positions and built successful teams while launching numerous products in pharmaceutical and biotech markets world-wide. Currently, David serves as the CEO of Boston IVF, one the largest IVF center networks in the United States with 11 full service IVF centers and over 30 satellite centers nationwide.
David served as CEO of Symbiomix Therapeutics a venture backed biotech company. He led the transition of the company from development stage to commercial launch in the US, prior to its acquisition by Lupin Pharmaceuticals in 2017. He served on the board of California Cryobank and has held executive positions in startup companies in the women’s healthcare market, building commercial teams, developing strategy and expanding scientific partnerships for Celmatix, Ohana and OvaScience.
David was the Senior Vice President and Head of the Global Business Franchise for Fertility at Merck Serono, responsible for the strategic development and growth of the portfolio world-wide. Prior to his global role, he was responsible for the US commercial operations in the Fertility, HIV and Growth Hormone markets. David started his career in women’s health with Organon Pharmaceutics. He has an MBA with a concentration in International Marketing and Management from the F.W. Olin School of Business at Babson College and holds a Bachelors’ degree in Biology from Brandeis University.
-
April Schweitzer
PartnerNixon PeabodyApril Schweitzer is a partner in Nixon Peabody’s Healthcare practice group and is based of Chicago. She partners with provider clients to address corporate and regulatory issues affecting hospitals, health systems, and physician groups. She also provides counsel regarding value-based contracting, clinical integration networks, and accountable care organizations. Specifically, April works with clients on transactional matters including mergers, acquisitions, and joint ventures, as well as corporate governance, licensure, tax exemption, and formation issues. She also provides counsel to clients regarding EMTALA, the federal Anti-Kickback Statute, the federal Stark law, and state law equivalents, and Medicare and Medicaid regulatory compliance, including voluntary self-disclosures.
-
Juan Camilo Arjona Ferreira
Head of Research & Development and Chief Medical OfficerOrganon -
Alexandra Busto
PartnerNixon Peabody LLPAlex Busto is a senior associate in Nixon Peabody’s Healthcare practice group and is based out of Los Angeles. She works with academic medical centers, hospitals, surgery centers, foundations and clinics, medical groups/IPAs, in-vitro fertilization and reproductive service providers, telehealth companies, MSOs, and other entities affiliated with the healthcare industry. Alex works closely with clients on transactional matters, and advises on multi-state expansion and growth, hospital/physician alignment, joint ventures, acquisitions, and other strategic transactions. In connection with these transactions, her practice also includes providing regulatory counsel with respect to federal and state compliance with physician self-referral, anti-kickback, licensing and certification, and other healthcare compliance matters.
-
Charlotte Owens
Head of Medical Affairs & Outcomes ResearchOrganon -
Dr Lyndsey Harper MD, FACOG IF
Founder & CEORosy Wellness -
Maia Gokhale
Vice President, Partner SuccessMae -
Thomas F. McElrath
Associate Professor, Harvard Medical SchoolBrigham and Women’s HospitalThomas F. McElrath, MD, PhD: Dr McElrath is a Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Professor of Epidemiology at the Harvard TH Chan School of Public Health. For 25 years he has served as an attending physician in Maternal-Fetal Medicine at The Brigham and Women’s Hospital in Boston where he is the Director of the Preterm Birth Clinic and Principal Investigator of the LIFECODES birth cohort. He has a PhD in Mathematical Demography with ongoing research interests in two areas: the effects of environmental toxicant exposures in pregnancy and the utilization of biomarkers for the prediction of preterm birth and associated pregnancy complications.
-
Dr. Sophia Yen
Co-founder and Chief Medical OfficerPandia Health
